DAPT ‘Too Strong’ After CABG for Heart Attacks, Trial Says

(MedPage Today) — MADRID — Dual antiplatelet therapy (DAPT) didn’t improve outcomes after coronary artery bypass grafting (CABG) for an acute coronary syndrome (ACS) but did increase risks, the TACSI randomized trial showed.
With ticagrelor…